FDA Approves Pfizer COVID-19 Vaccine For Use In Children

File image by Heather Hazzan / SELF Magazine / CC BY 2.0

WASHINGTON – The U.S. Food and Drug Administration has approved the Pfizer COVID-19 Vaccine for use in children. 

The agency announced the expanded emergency use authorization for the Pfizer-BioNTech COVID-19 Vaccine on Tuesday evening.  

The two-dose vaccine can now be administered to adolescents 12 to 15 years of age. 

Acting FDA Commissioner Janet Woodcock, M.D., made the following statement on the expansion:

“The FDA’s expansion of the emergency use authorization for the Pfizer-BioNTech COVID-19 Vaccine to include adolescents 12 through 15 years of age is a significant step in the fight against the COVID-19 pandemic,” said Dr. Woodcock. “Today’s action allows for a younger population to be protected from COVID-19, bringing us closer to returning to a sense of normalcy and to ending the pandemic. Parents and guardians can rest assured that the agency undertook a rigorous and thorough review of all available data, as we have with all of our COVID-19 vaccine emergency use authorizations.” 

Pfizer was the first vaccine approved in the fight against the COVID-19 pandemic, back in December of 2020. 


1 Comment

  1. So your headline is very misleading! the FDA has NOT “approved” the Vaccine AT ALL!
    they’ve released it under the Emergency Use Act! RELECED not APPROVED! you folks will be judged and He Is Watching!!!!!!!!!

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.